Postes actifs de Andreas Katopodis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Directeur Général | 01/04/2018 | - |
| Fondateur | 01/04/2018 | - |
Historique de carrière de Andreas Katopodis
Statistiques
Internationale
| Suisse | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Health Technology |
- Bourse
- Insiders
- Andreas Katopodis
- Expérience
